MiMedx Group, Inc

MDXG Healthcare Biotechnology

MiMedx Group, Inc’s revenue for fiscal 2025 (year ended December 2025) was $418.6 million, up 20.0% from fiscal 2024. In the quarter to June 2026, revenue fell 34.7%, EPS fell 242.9%, free cash flow fell 174.8% and total debt fell 6.80%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

4.43 0.25 −5.34%
Market cap
$682.2M
P/E
111×
Fwd P/E
−31.2×
Dividend yield
—
F-score
5/9
Altman Z
9.38
Beneish M
−2.68
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Total current assets
126.54 48.75 74.05 123.25 160.62 148.52 134.20 164.26 191.89 277.47
Total non-current assets
66.73 72.51 48.80 43.92 41.42 39.41 37.23 74.79 72.03 65.18
Total Assets
193.26 121.26 122.84 167.17 202.03 187.93 171.43 239.05 263.92 342.65
Total current liabilities
50.73 45.81 71.55 67.32 59.16 42.36 43.56 46.01 45.60 64.27
Total non-current liabilities
9.53 1.65 1.64 65.45 143.02 145.49 145.86 50.32 25.21 21.84
Total liabilities
60.26 47.46 73.19 132.77 202.18 187.85 189.42 96.33 70.81 86.11
Common Equity (Total)
133.00 73.80 49.66 34.40 (0.15) 0.08 (17.99) 142.72 193.11 256.55
Shareholders Equity (Total)
133.00 73.80 49.66 34.40 (0.15) 0.08 (17.99) 142.72 193.11 256.55
Total Debt
0.03 0.29 0.23 65.66 48.87 49.38 50.03 49.10 18.83 17.97

Show all line items

In millions of $ except per-share values · columns are period end dates